Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Martina Croce und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Psychotropic Drugs, Saliva, Substance Abuse Detection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Università di Roma, Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
Over the past decade, there has been a diversification of the psychoactive substances available among drug users, resulting in the expansion of a dynamic market of synthetic molecules that are challenging for drug of abuse testing. Multiclass analytical methods are useful to deal with these new psychoactive substances (NPS), but sample preparation can be difficult and generate significant amounts of chemical waste. The aim of this work was the development of a high‐throughput microextraction method for the determination of 56 drugs belonging to different pharmacological classes in oral fluid (OF), including both traditional drugs and NPS. In the proposed workflow, the OF sample is cleaned‐up by parallel artificial liquid membrane extraction (PALME) and analyzed by liquid chromatography–tandem mass spectrometry (LC–MS/MS). Two hundred microliters of OF are mixed with 1800 μL of carbonate buffer 0.5 M (pH 12) and 0.4 g of sodium chloride and inserted into a donor plate; the acceptor plate embed a dodecylacetate‐supported liquid membrane and an acceptor solution composed of 50 μL formic acid 0.1% in H2O: MeOH, 80:20 (v/v); the whole assemblage is placed on an orbital shaker for 120 min for extraction. A full factorial design has been employed for extraction optimization to make it suitable for LC–MS/MS. The developed method is an example of green chemistry and may be used for screening and quantitative purposes, with limits of detection ranging from 0.01 to 1.5 ng mL −1 and optimal performance in term of precision and accuracy for 49 out of 56 drugs tested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
- Department of Chemistry, Sapienza University of Rome, Rome, Italy.
- Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Teramo, Italy.
ORCID-Profile: Camilla Montesano
Förderung
- Sapienza Università di Roma
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Croce, M., Montesano, C., Bracaglia, I., Bartolini, F., Mascini, M., Compagnone, D., & Sergi, M. (2025). Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS. Drug Testing and Analysis. https://doi.org/10.1002/dta.3894
Vancouver
Croce M, Montesano C, Bracaglia I, Bartolini F, Mascini M, Compagnone D, et al. Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS. Drug Testing and Analysis. 2025. doi:10.1002/dta.3894
BibTeX
@article{Croce2025,
author = {Croce, Martina and Montesano, Camilla and Bracaglia, Ilenia and Bartolini, Francesco and Mascini, Marcello and Compagnone, Dario and Sergi, Manuel},
title = {Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3894}
}
EUVIMED